Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Infect ; 56(6): 469-73, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18440071

RESUMO

OBJECTIVES: Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae involving cutaneous tissue and peripheral nerves producing skin lesions, nerve degeneration, anaesthesia and deformities. In leprosy, the activated phagocytes produce reactive oxygen species (ROS) as a part of their microbicidal function. Such ROS are capable of damaging the host tissue by lipid peroxidation. Increased lipid peroxidation has been reported in leprosy. The glutathione antioxidant system with glutathione peroxidase (GSH-Px), glutathione reductase (GR) and glutathione (GSH) as components protect the cells from ROS toxicity and lipid peroxidation. The objective of the present study was to assess blood glutathione content and erythrocyte antioxidant enzyme activities of glutathione peroxidase and glutathione reductase in leprosy. DESIGN: The parameters were studied in 100 leprosy patients and 50 normal healthy controls. The data was analysed by grouping the patients into Ridley-Jopling (RJ) types [tuberculoid leprosy (TT), borderline tuberculoid leprosy (BT), borderline leprosy (BB), borderline lepromatous leprosy (BL), lepromatous leprosy (LL)] and into different levels of Bacteriological Index (BI) [bacteriologically negative (BI=0), BI=0.1-1, BI=1.1-2, BI=2.1-3, BI=3.1-4, BI=4.1-6]. METHODS: Venous blood sample was used for the study. The GSH level was estimated in the blood by DTNB [5,5'-dithiobis(2-nitrobenzoic acid)] reduction method. The enzyme activities were measured in the red blood cell haemolysate by kinetic methods using NADPH. RESULTS: GSH, GSH-Px and GR were significantly low in leprosy (total patients) as compared to the control group (p<0.001). A progressive decrease in GSH level and enzyme activities was noted along the leprosy spectrum from TT to LL. A significant decline of GSH in BB (p<0.05), BL (p<0.005) and LL (p<0.001); and of GSH-Px and GR in BT (p<0.05, p<0.02), BB (p<0.02), BL (p<0.005) and LL (p<0.001) was noted as compared to controls. A significant lowering of GSH-Px in LL (p<0.005); the GR in BB (p<0.02), BL (p<0.05) and LL (p<0.05); and the GSH in BL (p<0.01) and LL (p<0.001) was noted in comparison to the TT group. The GSH and GSH-Px were significantly low in LL (p<0.05) as compared to BT. A progressive decreasing trend in GSH level and enzyme activities was also noticed along the leprosy groups with advancing level of BI. The GSH, GSH-Px and GR were significantly low in BI levels 1.1-2 (p<0.005, p<0.05, p<0.02), 2.1-3 (p<0.005, p<0.001, p<0.005), 3.1-4 (p<0.005) and 4.1-6 (p<0.01, p<0.005, p<0.05) as compared to controls. A significant decline in GSH was noted in BI levels 1.1-2 (p<0.005), 2.1-3 (p<0.005), 3.1-4 (p<0.005) and 4.1-6 (p<0.01) as compared to the bacteriologically negative group. The GSH-Px (p<0.05) and GR (p<0.05) were significantly low in BI levels 2.1-3, 3.1-4 and 4.1-6 as compared to the bacteriologically negative group. CONCLUSION: The findings suggest oxidative stress associated with diminished antioxidant defence potential in leprosy. The study identifies association of diminished antioxidant potential with bacterial load and type of leprosy.


Assuntos
Eritrócitos/enzimologia , Glutationa Peroxidase/sangue , Glutationa Redutase/sangue , Glutationa/sangue , Hanseníase/sangue , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
2.
Lepr Rev ; 78(4): 391-7, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18309714

RESUMO

OBJECTIVES: To assess erythrocyte superoxide dismutase (SOD) and catalase (CAT) activities and hydrogen peroxide induced lipid peroxidation in leprosy. DESIGN: One hundred leprosy patients and 50 normal healthy controls were studied for the parameters. The data was analysed by grouping the patients into Ridley-Jopling (RJ) types [Tuberculoid leprosy (TT, n = 22), Borderline tuberculoid leprosy (BT, n = 28), Borderline leprosy (BB, n = 13), Borderline lepromatous leprosy (BL, n = 16) and Lepromatous leprosy (LL, n = 21)] and into different levels of Bacteriological Index (BI) [bacteriologically negative (n = 32), BI = 0.1-1 (n = 22), BI = 1.1-2 (n = 16), BI = 2.1-3 (n = 14), BI = 3.1-4 (n = 10) and BI = 4.1-6 (n = 06)]. RESULTS: The induced peroxidation was significantly high and the enzyme activities were significantly low in leprosy (total patients) as compared to controls. A progressive increase in peroxidation was detected along the leprosy spectrum from TT to LL and the increase was significant in BB, BL and LL groups as compared to controls. Induced peroxidation in LL group as compared to TT, BT and BB and in the BL group as compared to TT and BT were significantly different. A concomitant progressive decline in enzyme activity was detected along the leprosy spectrum from TT to LL. The SOD activity in BB, BL and LL and the CAT activity in BL and LL were significantly low as compared to controls. SOD activity in BB, BL and LL groups as compared to TT and in the LL group as compared to BT were significantly different. A progressive trend of increasing peroxidation and decreasing SOD and CAT activity were also detected along the leprosy groups with advancing level of BI. Induced peroxidation and SOD activity were significantly different in bacteriologically positive groups as compared to controls and in the BI levels 1.1-2, 2.1-3, 3.1-4 and 4.1-6 as compared to bacteriologically negative group. The peroxidation was significantly different in BI levels 2.1-3, 3.1-4 and 4.1-6 as compared to BI level 0.1-1. The CAT activity was significantly different in BI levels 2.1-3, 3.1-4 and 4.1-6 as compared to controls. CONCLUSION: The study findings suggest oxidative stressful state associated with reduced antioxidant defence potential in erythrocytes of leprosy patients. The study implicates association of erythrocyte oxidative stress with bacterial load and type of leprosy.


Assuntos
Catalase/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Peróxido de Hidrogênio , Hanseníase/enzimologia , Peroxidação de Lipídeos , Superóxido Dismutase/efeitos dos fármacos , Adulto , Estudos de Casos e Controles , Eritrócitos/enzimologia , Feminino , Humanos , Hanseníase/patologia , Hanseníase Dimorfa/enzimologia , Hanseníase Dimorfa/patologia , Hanseníase Virchowiana/enzimologia , Hanseníase Virchowiana/patologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...